Absolute configuration and biological profile of pyrazoline enantiomers as MAO inhibitory activity

Chirality. 2019 Jan;31(1):21-33. doi: 10.1002/chir.23027. Epub 2018 Nov 23.

Abstract

A new racemic pyrazoline derivative was synthesized and resolved to its enantiomers using analytic and semipreparative high-pressure liquid chromatography. The absolute configuration of both fractions was established using vibrational circular dichroism. The in vitro monoamine oxidase (MAO) inhibitory profiles were evaluated for the racemate and both enantiomers separately for the two isoforms of the enzyme. The racemic compound and both enantiomers were found to inhibit hMAO-A selectively and competitively. In particular, the R enantiomer was detected as an exceptionally potent and a selective MAO-A inhibitor (Ki = 0.85 × 10-3 ± 0.05 × 10-3 μM and SI: 2.35 × 10-5 ), whereas S was determined as poorer compound than R in terms of Ki and SI (0.184 ± 0.007 and 0.001). The selectivity of the enantiomers was explained by molecular modeling docking studies based on the PDB enzymatic models of MAO isoforms.

Keywords: 2-pyrazoline; molecular modeling docking; monoamine oxidase inhibitory activity; specific rotation; stereochemistry; vibrational circular dichroism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Circular Dichroism
  • Hep G2 Cells
  • Humans
  • Kinetics
  • Models, Molecular
  • Molecular Docking Simulation
  • Molecular Structure
  • Monoamine Oxidase / genetics
  • Monoamine Oxidase / metabolism
  • Monoamine Oxidase Inhibitors / chemical synthesis
  • Monoamine Oxidase Inhibitors / chemistry*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Pyrazoles / chemical synthesis
  • Pyrazoles / chemistry*
  • Pyrazoles / pharmacology*
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Monoamine Oxidase Inhibitors
  • Pyrazoles
  • Monoamine Oxidase